Suppr超能文献

用 N'-芳基-N-羟基脲抑制细菌和硅藻中的 α-、β-、γ-和 δ-碳酸酐酶。

Inhibition of α-, β-, γ-, and δ-carbonic anhydrases from bacteria and diatoms with N'-aryl-N-hydroxy-ureas.

机构信息

a Dipartimento Neurofarba, Sezione di Scienze Farmaceutiche e Nutraceutiche , Università degli Studi di Firenze , Florence , Italy.

b CNR , Istituto di Bioscienze e Biorisorse , Napoli , Italy.

出版信息

J Enzyme Inhib Med Chem. 2018 Dec;33(1):1194-1198. doi: 10.1080/14756366.2018.1490733.

Abstract

The inhibition of α-, β-, γ-, and δ-class carbonic anhydrases (CAs, EC 4.2.1.1) from bacteria (Vibrio cholerae and Porphyromonas gingivalis) and diatoms (Thalassiosira weissflogii) with a panel of N'-aryl-N-hydroxy-ureas is reported. The α-/β-CAs from V. cholerae (VchCAα and VchCAβ) were effectively inhibited by some of these derivatives, with Ks in the range of 97.5 nM - 7.26 µM and 52.5 nM - 1.81 µM, respectively, whereas the γ-class enzyme VchCAγ was less sensitive to inhibition (Ks of 4.75 - 8.87 µM). The β-CA from the pathogenic bacterium Porphyromonas gingivalis (PgiCAβ) was not inhibited by these compounds (Ks > 10 µM) whereas the corresponding γ-class enzyme (PgiCAγ) was effectively inhibited (Ks of 59.8 nM - 6.42 µM). The δ-CA from the diatom Thalassiosira weissflogii (TweCAδ) showed effective inhibition with these derivatives (Ks of 33.3 nM - 8.74 µM). As most of these N-hydroxyureas are also ineffective as inhibitors of the human (h) widespread isoforms hCA I and II (Ks > 10 µM), this class of derivatives may lead to the development of CA inhibitors selective for bacterial/diatom enzymes over their human counterparts and thus to anti-infectives or agents with environmental applications.

摘要

报告了一组 N'-芳基-N-羟基脲对来自细菌(霍乱弧菌和牙龈卟啉单胞菌)和硅藻(威氏海链藻)的α-、β-、γ-和δ-碳酸酐酶(CA,EC 4.2.1.1)的抑制作用。这些衍生物有效地抑制了霍乱弧菌(VchCAα 和 VchCAβ)的α-/β-CA,Ks 值分别在 97.5 nM - 7.26 μM 和 52.5 nM - 1.81 μM 范围内,而γ-类酶 VchCAγ 对抑制作用的敏感性较低(Ks 为 4.75 - 8.87 μM)。来自致病菌牙龈卟啉单胞菌的β-CA(PgiCAβ)不受这些化合物的抑制(Ks > 10 μM),而相应的γ-类酶(PgiCAγ)则被有效抑制(Ks 值为 59.8 nM - 6.42 μM)。硅藻威氏海链藻(TweCAδ)的δ-CA 也被这些衍生物有效抑制(Ks 值为 33.3 nM - 8.74 μM)。由于这些 N-羟基脲类化合物对人(h)广泛存在的同工酶 hCA I 和 II 的抑制作用也不明显(Ks > 10 μM),因此,这类衍生物可能会导致开发出对细菌/硅藻酶具有选择性的 CA 抑制剂,而对其人类同工酶则没有选择性,从而开发出抗感染药物或具有环境应用的药物。

相似文献

引用本文的文献

5
An overview on the recently discovered iota-carbonic anhydrases.关于最近发现的ι-碳酸酐酶的概述。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):1988-1995. doi: 10.1080/14756366.2021.1972995.

本文引用的文献

6
Antiglaucoma carbonic anhydrase inhibitors: a patent review.抗青光眼碳酸酐酶抑制剂:专利研究综述。
Expert Opin Ther Pat. 2013;23(6):705-16. doi: 10.1517/13543776.2013.794788. Epub 2013 Apr 30.
7
Antiobesity carbonic anhydrase inhibitors: a literature and patent review.抗肥胖碳酸酐酶抑制剂:文献与专利述评。
Expert Opin Ther Pat. 2013;23(6):725-35. doi: 10.1517/13543776.2013.790957. Epub 2013 Apr 22.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验